scholarly journals Amino acid sequence of the N-terminal sixty-nine residues of heavy chain derived from a homogeneous rabbit antibody

1972 ◽  
Vol 130 (2) ◽  
pp. 539-546 ◽  
Author(s):  
Jean-Claude Jaton ◽  
D. G. Braun

The sequence of the N-terminal 69 residues of heavy chain from a homogeneous rabbit antibody to type III pneumococcal polysaccharide was determined. The sequence is similar to that found in heavy chains of normal pooled rabbit immunoglobulins of the same allotype Aa1. Two regions of the homogeneous heavy chain (residues 35–46 and 62–69) are very similar to corresponding regions of heavy chains from rabbit Aa2 immunoglobulin, as well as from mouse, guinea-pig and human immunoglobulins. In contrast, residues 47–62 appear to be variable. Comparison in this section with another homogeneous anti-pneumococcal antibody (Strosberg et al., 1972) of related specificity and of the same allotype indicates sequence variation in at least three positions. An antibody to group C streptococcal carbohydrate of allotype Aa2 (Fleischman, 1971) differs by five amino acids in the same region of the heavy chain. Sequence variability between these three antibodies does not occur in homologous positions within this variable section. Allotype-related sequences could not be identified in section 34–65.

1974 ◽  
Vol 139 (1) ◽  
pp. 281-283 ◽  
Author(s):  
Jean-Claude Jaton ◽  
Joseph Haimovich

The amino acid sequence of the N-terminal 48 residues of the heavy chain derived from a homogeneous rabbit antibody to type III pneumococci is described. This chain of allotype a2 is compared with other rabbit heavy chains of allotypes a1, a2 and a3. Within the N-terminal 25 positions, two chains which carry the same allotype a2 possess identical amino acid sequences, but differ markedly from heavy chains of allotypes a1 and a3. Sequence variability is observed in residues 26–27 and 30–34, but not in residues 35–48.


1971 ◽  
Vol 124 (2) ◽  
pp. 301-318 ◽  
Author(s):  
L. E. Mole ◽  
S. A. Jackson ◽  
R. R. Porter ◽  
J. M. Wilkinson

The sequence has been completed of the N-terminal 94 residues of the variable section of the Fd fragment of heavy chains from rabbit immunoglobulin G (IgG) of allotype As1. Most of the sequence of the same section from IgG of allotype Aa3 is also reported. These results, in conjunction with a substantial sequence of the variable region of allotype Aa2 reported elsewhere (Fleischman, 1971), show the presence of 16 positions (including six consecutive positions) in which the residue present correlates with the allotype. No allotype-related sequence variation has been found in the constant section of the Fd fragment. This evidence supports the view that two genes code for the heavy chain and it can be used as evidence in favour of somatic mutation as the origin of the variability in the sequence of the N-terminal section. The evolutionary origin of the ‘a’ locus allotypes of rabbit immunoglobulins remains obscure.


1974 ◽  
Vol 139 (1) ◽  
pp. 135-149 ◽  
Author(s):  
Christopher E. Fisher ◽  
Elizabeth M. Press

The binding sites of rabbit antibodies with affinity for the haptenic group 4-azido-2-nitrophenyl-lysine have been specifically labelled by photolysis of the hapten–antibody complex. The extent of covalent labelling was 0.5–0.9mol of hapten bound/mol of antibody and, by using an immunoadsorbent, antibody with 1.3mol of hapten/mol was obtained. The antibody was specifically labelled in the binding site and the ratio of labelling of heavy and light chains was in the range 3.3–5.0. The labelled heavy chains were cleaved by CNBr treatment and after reduction and alkylation of the intrachain bonds, were digested with trypsin. Evidence is presented that two regions of the heavy chain, positions 29–34 and 95–114, together contain about 80% of the label on the heavy chain; these two regions respectively include two of the hypervariable regions of rabbit heavy chain.


1987 ◽  
Vol 247 (1) ◽  
pp. 15-21 ◽  
Author(s):  
J Kellermann ◽  
C Thelen ◽  
F Lottspeich ◽  
A Henschen ◽  
R Vogel ◽  
...  

The arrangement of the disulphide bridges in human low-Mr kininogen has been elucidated. Low-Mr kininogen contains 18 half-cystine residues forming nine disulphide bridges. The first and the last half-cystine residues of the amino acid sequence form a disulphide loop which spans the heavy- and the light-chain portion of the kininogen molecule. The other 16 half-cystine residues are linked consecutively to form eight loops of 4-20 amino acids; these loops are lined up in the heavy-chain portion of the kininogen molecule. In this way, a particular pattern of disulphide loops is formed which seems to be of critical importance for the inhibitor function of human kininogen.


1968 ◽  
Vol 106 (1) ◽  
pp. 15-21 ◽  
Author(s):  
B. Frangione ◽  
C. Milstein ◽  
Edward C. Franklin

The disulphide bridges of the Fc fragment (C-terminal half of the heavy chain) have been studied in several human immunoglobulins, containing heavy chains of different antigenic types (γ1, γ2, γ3 and γ4), and in heavy-chain-disease proteins. Two intrachain disulphide bridges were found to be present. The sequences appear to be identical in the Fc fragments of two types of chain studied (γ1 and γ3), and very similar to corresponding sequences of the Fc fragment in rabbit. These results suggest that the C-terminal half of the heavy chains is covalently folded (in a similar fashion to the light chains) with a C-terminal loop and an N-terminal loop. The similarity is emphasized by comparison of the sequence and location of the disulphide-bridged peptides of the C-terminal loop of heavy and light chains. The N-terminal loop, on the other hand, appears to be very different in Fc fragments and light chains. The C-terminal loop is the only one present in the F′c fragment.


1971 ◽  
Vol 121 (2) ◽  
pp. 217-225 ◽  
Author(s):  
C. Milstein ◽  
B. Frangione

Amino acid sequences around the disulphide bridges of the heavy chain of an immunoglobulin of the γ2 subclass have been studied. The protein was digested with pepsin and the digest fractionated by Sephadex. Screening of the eluate by one-dimensional electrophoresis of oxidized and unoxidized samples was used as an assay and pools of fractions were prepared. Identification by diagonal electrophoresis of several inter- and intra-chain disulphide bridges was done on the pooled fractions. The inter-heavy-chain bridged peptide included four cystine residues. Comparison with proteins of other human subclasses indicated that the intrachain bridges identified are the bridges of the invariable section of γ2 heavy chains. The amino acid sequence of one cysteic acid peptide that may have been derived from the variable part of the molecule was determined. Partial reduction followed by carboxymethylation with radioactive iodoacetate of two proteins of the γ2 class showed a number of labelled peptides that could be identified as being related to the inter-chain bonded cystine residues.


1981 ◽  
Vol 153 (5) ◽  
pp. 1275-1285 ◽  
Author(s):  
J Dickerman ◽  
B Clevinger ◽  
B Friedenson

Two dextran-binding myeloma proteins, J558 and Hdex 24, which possess the same individual idiotype (IdI) were diazotized to low levels (1-3.3 groups per subunit) with 1-[14C]-p-aminobenzoate. Both proteins lost the IdI idiotype under these conditions with most of the label incorporated on the heavy chains of each protein. When the diazotization ws carried out in the presence of the hapten 1-O-methyl-alpha-D-glucopyranoside the loss of idiotypic reactivity could be prevented for J558 but not for Hdex 24. Under these conditions most of the label was incorporated on the light chains of J558, but on the heavy chains of Hdex 24. For J558, these results show that a major determinant of the individual idiotype is within the hypervariable positions of the heavy chain. For Hdex 24 the determinant being modified is on the heavy chain but not involved in hapten binding. These results are consistent with previous work showing that J558 and Hdex 24 differ in amino acid sequence in the D and the J segments of the heavy chain and offer an alternative and complementary strategy for assigning idiotypic determinants.


1966 ◽  
Vol 166 (1003) ◽  
pp. 150-158 ◽  

The combining site of an antibody is entirely contained in the papain digest fragments known as Fab (see Cohen, figure 1, this discussion). These are formed from the light chains and the amino terminal half of the heavy chains known as the Fd fragments. Evidence from many laboratories suggests that the Fd fragment contains the combining site, but it is still uncertain whether the light chain is directly involved in the site, or whether it plays a secondary role in stabilizing the structure of the Fd fragment (see Fleischman 1966). We are attempting, therefore, to determine the chemical structure of the Fd fragment. The evidence of Haber (1964) and Whitney & Tanford (1965) showed that the secondary and tertiary structure of the Fab fragment of several rabbit antibodies could be completely disrupted by reduction of all the disulphide bonds in 6 M guanidine, and that, if such fully denatured molecules were allowed to refold under appropriate conditions, there was a small but significant recovery of affinity for the antigen. These experiments suggest that the specificity of the antibody-combining site is determined by the amino acid sequence of the peptide chain and hence that each antibody specificity would be expected to be reflected in a unique sequence in certain sections of the Fd fragment. It was expected that elucidation of the sequence of this part of the heavy chain would be difficult, as it was evident from earlier work on the amino terminal amino acids of immunoglobulin G (IgG) from several species that mixed sequences were to be expected, and that these may be unrelated to antibody specificity. Hence, considerable variability was probable, only part of which was likely to be related to antibody specificity. On the other hand, some sections of constant sequence should be present, as the Fd fragment contains the interchain disulphide bond between the heavy and light chains and possibly a heavy-heavy interchain bond, as well as the allotypic antigenic sites of the rabbit IgG heavy chain (see Oudin, this discussion). All three features are common to all molecules in a pre­paration of IgG from molecules homozygous at the allotypic locus, and hence it would be expected that they would be located in stable sections of amino acid sequence in Fd fragment. The problem has been tackled in two ways. (1) Work has been commenced with a pathological human IgG which is believed to have a single amino acid sequence and hence can be studied by conventional techniques. Homology between the sequences of several proteins from different mammalian species, suggests that the results will be a valuable guide to what may be expected in IgG from other species such as rabbit, from which purified antibodies may be much more easily prepared. In particular we were fortunate in obtaining a patho­logical human protein the heavy chain of which had a blocked amino terminal amino group, as is found in the rabbit IgG heavy chain and hence the sequence of this protein is being studied. (2) There has never been any convincing demonstra­tion, however, that pathological immunoglobulins have antibody activity, and it is possible that this property may be dependent on some special feature not present, or difficult to recognize, in the pathological protein. Work is also being carried out therefore on the sequence of the Fd fragment of rabbit IgG which has been pre­pared from non-immunized rabbits, from rabbits homozygous at the allotypic locus and from purified rabbit antibodies. Mixed amino acid sequences are found in all these preparations. This precludes a straightforward solution of the sequence and hence attention has been directed to the sequences adjacent to known points such as the amino and carboxyl terminals and the interchain disulphide bonds where it is possible to estimate the relative content of different sequences at these fixed points, and to determine if there is any relation to the known variables of antibody specifi­city and allotypy.


Sign in / Sign up

Export Citation Format

Share Document